Oncolytic Virotherapy of Canine and Feline Cancer

被引：28
|
作者：
Gentschev, Ivaylo [1 ,2 ]
Patil, Sandeep S. [1 ]
Petrov, Ivan [1 ]
Cappello, Joseph [2 ]
Adelfinger, Marion [1 ]
Szalay, Aladar A. [1 ,2 ,3 ]
机构：
[1] Univ Wurzburg, Dept Biochem, D-97074 Wurzburg, Germany
[2] Genelux Corp, San Diego Sci Ctr, San Diego, CA 92109 USA
[3] Univ Calif San Diego, Rebecca & John Moores Comprehens Canc Ctr, Dept Radiat Med & Appl Sci, La Jolla, CA 92093 USA
来源：
VIRUSES-BASEL | 2014年 / 6卷 / 05期
关键词：
cancer; canine and feline cancer therapy; oncolytic virus; oncolysis; HERPES-SIMPLEX-VIRUS; CELL-BASED DELIVERY; VACCINIA VIRUS; THYMIDINE KINASE; GENE-THERAPY; TUMOR-CELLS; NUDE-MICE; IN-VITRO; PET DOGS; ADENOVIRUS;
D O I：
10.3390/v6052122
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Cancer is the leading cause of disease-related death in companion animals such as dogs and cats. Despite recent progress in the diagnosis and treatment of advanced canine and feline cancer, overall patient treatment outcome has not been substantially improved. Virotherapy using oncolytic viruses is one promising new strategy for cancer therapy. Oncolytic viruses (OVs) preferentially infect and lyse cancer cells, without causing excessive damage to surrounding healthy tissue, and initiate tumor-specific immunity. The current review describes the use of different oncolytic viruses for cancer therapy and their application to canine and feline cancer.
引用
收藏
页码：2122 / 2137
页数：16
相关论文
共 50 条
  • [21] Oncolytic virotherapy
    Cervantes-Garcia, Daniel
    Ortiz-Lopez, Rocio
    Mayek-Prez, Netzahualcoyotl
    Rojas-Martinez, Augusto
    ANNALS OF HEPATOLOGY, 2008, 7 (01) : 34 - 45
  • [22] Bugs and Drugs: Oncolytic Virotherapy in Combination with Chemotherapy
    Wennier, Sonia Tusell
    Liu, Jia
    McFadden, Grant
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2012, 13 (09) : 1817 - 1833
  • [23] Telomerase-specific oncolytic virotherapy for human gastrointestinal cancer
    Fujiwara, Toshiyoshi
    Shirakawa, Yasuhiro
    Kagawa, Shunsuke
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (04) : 525 - 532
  • [24] Oncolytic Virotherapy Treatment of Breast Cancer: Barriers and Recent Advances
    Kwan, Amy
    Winder, Natalie
    Muthana, Munitta
    VIRUSES-BASEL, 2021, 13 (06):
  • [25] Recent patents in oncolytic virotherapy
    Ahmad, Tauqeer
    Venkataraman, Srividhya
    AbouHaidar, Mounir
    Hefferon, Kathleen L.
    Recent Patents on Biotechnology, 2015, 9 (02) : 79 - 85
  • [26] Oncolytic virotherapy: Challenges and solutions
    Goradel, Nasser Hashemi
    Baker, Alexander T.
    Arashkia, Arash
    Ebrahimi, Nasim
    Ghorghanlu, Sajjad
    Negahdari, Babak
    CURRENT PROBLEMS IN CANCER, 2021, 45 (01)
  • [27] Oncolytic Polio Virotherapy of Cancer
    Brown, Michael C.
    Dobrikova, Elena Y.
    Dobrikov, Mikhail I.
    Walton, Ross W.
    Gemberling, Sarah L.
    Nair, Smita K.
    Desjardins, Annick
    Sampson, John H.
    Friedman, Henry S.
    Friedman, Allan H.
    Tyler, Douglas S.
    Bigner, Darell D.
    Gromeier, Matthias
    CANCER, 2014, 120 (21) : 3277 - 3286
  • [28] Oncolytic Virotherapy Reaches Adolescence
    Hammill, Adrienne M.
    Conner, Joseph
    Cripe, Timothy P.
    PEDIATRIC BLOOD & CANCER, 2010, 55 (07) : 1253 - 1263
  • [29] Oncolytic virotherapy of gynecologic malignancies
    Hartkopf, Andreas D.
    Fehm, Tanja
    Wallwiener, Diethelm
    Lauer, Ulrich
    GYNECOLOGIC ONCOLOGY, 2011, 120 (02) : 302 - 310
  • [30] Oncolytic virotherapy for thyroid cancer: will it translate to the clinic?
    Passaro, Carmela
    Portella, Giuseppe
    INTERNATIONAL JOURNAL OF ENDOCRINE ONCOLOGY, 2015, 2 (01) : 5 - 8
12345